$SWISF 200X incoming - Sekur Private Data Ltd. is a

New Post Public Reply Private Reply Replies (0) Message Board
teabiscuitbreeder
132
$SWISF 200X incoming - Sekur Private Data Ltd. is a Swiss-hosted cybersecurity and privacy communications provider. offering a secure suite of tools to protect governments, businesses and individuals from unauthorized access and cyber threats. With solutions such as SekurMail, SekurMessenger, and SekurVPN, Sekur provides an accessible and reliable means of digital communication and data storage, grounded in Swiss privacy standards. Sekur sells its solutions through its website www.sekur.com, approved distributors and telecommunications companies globally. Sekur serves governments, businesses and consumers worldwide.

Sekur Market Expansion Overview (2025–2026)

1. U.S. GSA Market Opportunity
Sekur is targeting the U.S. government market—specifically state/local and federal agencies—through its GSA (General Services Administration) schedule.
Target Users: 1.1 million (5% of 22 million total addressable users)
Pricing Range: $900–$1,500 per user annually
Revenue Potential: $1.44 billion per year
Profit Margin (after partner payout): 75% This segment leverages government privacy and compliance mandates (CISA, NIST) and focuses on reliable, multi-year government contracts expected to drive stable recurring revenue and agency-wide adoption.

2. Africa (DRC & Angola) Market Opportunity – by End of 2028
Sekur’s African expansion focuses on government and corporate clients in the Democratic Republic of Congo (DRC) and Angola, partnering with regional telecom operators (Orange, Vodacom, Unitel).
Total Target Users: 230,000 (5% of 1 million+ addressable)
Blended Pricing: $350–$1,500 per user annually
Revenue Potential: $123 million annually
Profit Margin (after partner payout): 60% The opportunity is driven by growing demand for secure communications in government and enterprise sectors, supported by established telecom distribution.

3. LATAM Market Opportunity
Sekur’s Latin American (LATAM) strategy is anchored by América Móvil partnerships (Telcel and Claro) in Mexico, Colombia, and Brazil.
Addressable Corporate Users: 6.9 million
Target Users (5%): 345,000
Price/User: $300 per year
Revenue Potential: $103 million annually
Profit Margin (after partner payout): 40% Sekur is positioned as the only privacy-focused SaaS platform with built-in telecom distribution across LATAM, enabling rapid, large-scale adoption through existing corporate networks.

4. 2025–2026 Milestones and Execution Timeline
Sekur’s roadmap shows a structured rollout across markets and products:
Q4 2025:
América Móvil Mexico corporate launch
SekurVoice development begins
GSA schedule confirmation
Q2 2026:
File Nasdaq uplisting
SekurVault completion
SekurWeb (anti-malware/privacy browser) development start
Q3 2026:
SekurMobile MVNO launch
SekurVoice & Video launch
Expansion across Africa & LATAM
Q4 2026:
Further regional expansions (Africa, LATAM 3rd country)

SekurWeb completion targeted for 2027
This timeline aligns major product rollouts, geographic expansions, and the Nasdaq uplisting into a cohesive growth plan—positioning Sekur for multi-market penetration and strong revenue scalability by 2026.
---

Screenshot-2025-10-28-134245.png
Screenshot-2025-10-28-135001.png
Screenshot-2025-10-28-135022.png
Screenshot-2025-10-28-135100.png

Deck: https://on24static.akamaized.net/event/51/21/...494369.pdf

GlobeX Data (SWISF) Stock Research Links

SWISF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 40

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Raytron Dominates Global Thermal Imaging Market in 2026

Updated Category News Views 106

Raytron's Market Supremacy: By the Numbers If you're looking at the thermal imaging sector and wondering what's what, take a clue from Raytron. This outfit isn't just playing the game—it's running the show with a staggering 30% of the global market in 2025. That's right, they hold the medal for leading global shipments in thermal imaging, and unlike many industries...

Continue Reading
Asphalt Additives Market Set for $7.07B Boom by 2031

Updated Category News Views 65

Asphalt Additives: A Lucrative Growth Path Let me tell you, the asphalt additives market isn't just sticking to the roads; it's rolling out real potential. Heading for a $7.07B finish line by 2031 with a steady pace of 7.3% CAGR, it's a road worth staking your claims on. The underlying story? It's more than just laying tar. Pavement to Profit: Key Drivers The asphalt...

Continue Reading
Pearl Meyer Leaders Grab NACD's Coveted Governance Honor

Updated Category News Views 26

NACD Recognition for Governance Grit Some folks just know how to steer a ship, and that's exactly what Pearl Meyer's Matt Turner and Jannice Koors have been doing. This year, they made it onto the NACD's 2026 Directorship 100 list, swinging as heavy hitters in the Governance Professionals category. It's not just another day at the office when you're honored by the...

Continue Reading
Epson Unveils Early Black Friday Tech Deals

Updated Category News Views 69

Diving Headfirst into Holiday Tech Splurging The holiday hustle is upon us, folks, and Epson's stepping up with early Black Friday deals that'll have tech heads scrambling. They’re cutting prices up to $250 on their swanky home lineup—projectors, printers, scanners, you name it. This ain't just about making someone else smile, though; it's about the sweet spot where...

Continue Reading
Doximity's Legal Woes: Class Action Deadline Looms

Updated Category News Views 15

The Truth Behind Doximity's Promises The brass tacks of investing often boil down to trust—a commodity that's now in short supply over at Doximity, Inc. (NYSE: DOCS). Investors have been left hanging after promises of lucrative engagement signals turned out to be a mere pipe dream. Levi & Korsinsky, LLP sounds the alarm on what's shaping up to be a high-stakes class...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading
Peanuts and Diabetes: A Surprising Health Link

Updated Category News Views 68

A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...

Continue Reading
Terra-Gen's $950M Lockhart Facility Powers California

Updated Category News Views 128

A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...

Continue Reading
Defense Contractors Push Forward Amid Indictments

Updated Category News Views 18

The Big Names Hold Steady Defense contractors are showing off their shiny earnings just as some disturbing headlines shake things up. It's like they're putting their best foot forward to steady the ship while the waters get choppy with terrorism charges and all sorts of geopolitical noise. Follow the smart money to see where the true bets are being placed—it all unfolds...

Continue Reading

Top 5 Most Recently Viewed Articles

Twilio's Q4 Results Spark Diverse Analyst Reactions

Updated Category News Views 232

Twilio Inc Fourth Quarter Overview Twilio Inc reported notable financial results for the fourth quarter, capturing the attention of several analysts within the market. The company’s performance has sparked diverse reactions, particularly regarding its future guidance and the evolving role of artificial intelligence within its operations. Market Response to Q4 Earnings...

Continue Reading
FHLBank Indianapolis Dividends for Second Quarter of 2025

Updated Category News Views 180

FHLBank Indianapolis Declares Second Quarter Dividends FHLBank Indianapolis recently announced its second quarter dividends for 2025, detailing robust financial strategies and growth, as reflected in the declared dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock. These dividends have been set at annualized rates of 9.50% and 4.50%,...

Continue Reading
Neurogen Biomarking Partners with Quanterix for Alzheimer's Testing

Updated Category News Views 255

Revolutionizing Alzheimer's Detection with Neurogen Biomarking Neurogen Biomarking is making significant strides in the healthcare landscape by introducing a pioneering blood test aimed at the early detection of Alzheimer's disease and Mild Cognitive Impairment (MCI). This innovative approach leverages advanced biomarker technology developed by Quanterix Corporation,...

Continue Reading
Kepler Robotics Launches Innovative Humanoid Robot for Industries

Updated Category News Views 296

Revolutionizing Industries with the K2 Bumblebee Shanghai Kepler Robotics Co., Ltd has excitedly announced the commencement of mass production of its K2 "Bumblebee" model, confirming that the world's first commercially available hybrid-architecture humanoid robot is now shipping to eager customers. Milestone in Humanoid Robotics This significant development not only marks...

Continue Reading
Syntara Limited Reveals Groundbreaking Data in Myelofibrosis Trials

Updated Category News Views 259

Positive Interim Data from Syntara's Clinical Trials Syntara Limited, known for its innovative approach in drug development, has unveiled promising interim data concerning its ongoing Phase 2 study of SNT-5505. This clinical trial focuses on myelofibrosis, a complex bone marrow disorder that often leads to severe health complications. Details of the Clinical Trial The...

Continue Reading